Prachi Pisal &Amp;Amp; Sanket Koul

Stories by Prachi Pisal &Amp;Amp; Sanket Koul

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com   3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

'Highways Infrastructure Trust's AUM to be around Rs 25,000'

'Highways Infrastructure Trust's AUM to be around Rs 25,000'

Rediff.com   31 Jan 2025

'By March-end, we should have closure of the PNC portfolio. After completion of PNC acquisition.'

US WHO Exit Won't Impact India: Experts

US WHO Exit Won't Impact India: Experts

Rediff.com   22 Jan 2025

'Both international cooperation and self-reliance will now acquire new purpose.'

Fake medicines worth Rs 6.6 crore seized in Kolkata

Fake medicines worth Rs 6.6 crore seized in Kolkata

Rediff.com   1 Jan 2025

'Anti-cancer, anti-diabetic, and other drugs suspected to be spurious were seized from the raid carried out at the firm.'

Offers Pour In At IITs' Placement Season

Offers Pour In At IITs' Placement Season

Rediff.com   24 Dec 2024

Major recruiters, with double-digit offers at IIT campuses this year so far, include American Express, Barclays, BCG, Cars24, Deutsche Bank, Goldman Sachs, Google, Intel India, Meesho, Micron Technology, Microsoft, OLA, Oracle, Reliance, and Qualcomm.

Raymond Realty may get listed in Q2FY26: CEO

Raymond Realty may get listed in Q2FY26: CEO

Rediff.com   9 Dec 2024

Raymond Limited's real estate arm, Raymond Realty, plans to get listed during the second quarter of the next financial year (Q2FY26), according to Harmohan Sahni, chief executive officer (CEO), Raymond Realty. "We are expecting the order by June-July 2025 as far as the National Company Law Tribunal (NCLT) is concerned.

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com   9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

Half of India Faces Glucose Imbalance

Half of India Faces Glucose Imbalance

Rediff.com   5 Dec 2024

'Obesity, especially central obesity and increased visceral fat due to physical inactivity, along with the consumption of high-calorie, high-fat, and high-sugar diets, are major contributing factors.'

Will Poll Gamechanger Laadki Bahin Continue?

Will Poll Gamechanger Laadki Bahin Continue?

Rediff.com   26 Nov 2024

'I wonder if they will keep it up after the elections.' 'I fear they'll start questioning eligibility -- income, age, bank accounts -- and eventually stop the scheme altogether.'

AQI Spike Triggers Health Crisis

AQI Spike Triggers Health Crisis

Rediff.com   20 Nov 2024

'Many of these patients arrive at emergency departments in distress, struggling to breathe and requiring immediate medical intervention.'

Employee Grievances Rise In Top Firms

Employee Grievances Rise In Top Firms

Rediff.com   4 Nov 2024

Data collated for 47 BSE50 companies (as of H1FY25) shows employees and workers filed 8,468 such complaints in FY24.

What's Driving Surge in Breast Cancer?

What's Driving Surge in Breast Cancer?

Rediff.com   1 Nov 2024

Late-stage diagnosis is a major issue, with over 75 per cent of cases being detected at advanced stages (50 per cent at Stage 3 and 25 per cent at Stage 4). This significantly reduces survival rates.

L&T eyes up to Rs 40K cr in pre-sales from realty business

L&T eyes up to Rs 40K cr in pre-sales from realty business

Rediff.com   7 Oct 2024

Buoyed by regulatory overhaul and infrastructure boom, engineering conglomerate Larsen & Toubro (L&T) has identified realty business as one of its growth engines for the next 10 years and plans to acquire land parcels while expanding pre-sales, said a senior company executive. L&T Realty has started looking out to acquire land parcels and grab partnership development opportunities across markets to scale up its business. "We are making some strides in that direction, albeit cautiously.

In Very Short Supply: Affordable Housing!

In Very Short Supply: Affordable Housing!

Rediff.com   5 Oct 2024

'Developers are into profit-making. And there's not too much money in the affordable segment.' 'So, they don't do affordable housing.'

Rise In Whistleblower Complaints In FY24

Rise In Whistleblower Complaints In FY24

Rediff.com   17 Sep 2024

'The global median of whistle-blower complaints is 1.5 per cent of the total employees. India's reporting is far away from this average.'

Mpox Puts Health System On High Alert

Mpox Puts Health System On High Alert

Rediff.com   17 Aug 2024

Strict screening protocols are to be implemented for passengers arriving from central African countries affected by the outbreak.

Ambanis Own 10% of India's Wealth

Ambanis Own 10% of India's Wealth

Rediff.com   9 Aug 2024

The Adani family, led by Chairman Gautam Adani, is the most valued first-generation family business at Rs 15.44 trillion.

Realtors cheer Centre's LTCG tax decision

Realtors cheer Centre's LTCG tax decision

Rediff.com   8 Aug 2024

The government's move to tweak the long-term capital gains (LTCG) tax regime proposed in the Finance Bill 2024 and re-introduce the indexation benefit is likely to boost the investments and spur housing sales in the country, industry executives believe. "By enabling taxpayers to choose the lower tax burden between the new and old schemes, the amendment is poised to drive investment and enhance sales across housing segments," said Niranjan Hiranandani, chairman of the Hiranandani Group. In Budget 2024, Union Finance Minister Nirmala Sitharaman proposed an overhaul in the capital gains tax regime, including lowering the LTCG tax to 12.5 per cent from 20 per cent.

Mankind Pharma to lead in Indian women's health market after BSV deal

Mankind Pharma to lead in Indian women's health market after BSV deal

Rediff.com   29 Jul 2024

New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women's health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to acquire Bharat Serums and Vaccines (BSV), senior company officials said. The deal potentially opens doors for Mankind Pharma to the overseas markets, which currently draws 92 per cent of its revenues from India. The combined entity will draw around 13 per cent revenues from the international market, with the remaining coming from the domestic market.